The Disconnect Between Tau Propagation, Pruning, and Glymphatic Failure

Recent data highlights a destructive triad in Alzheimer's disease: pathological synaptic pruning, tau propagation, and glymphatic collapse. We know that microglial phagocytosis via CR3 becomes overactivated in AD, paradoxically causing synaptic loss. Concurrently, K63-linked ubiquitination of tau oligomers specifically enhances their formation and secretion, spreading via exosome-mediated transfer. Meanwhile, extracellular tau clearance is heavily dependent on the glymphatic system, driven by AQP4-dependent water flux, which becomes impaired in tauopathy models.

However, a mechanistic gap remains: What explicitly links microglial synaptic pruning to the loss of astrocytic AQP4 polarization and subsequent glymphatic failure?

The Hypothesis: A Senescence-Driven Feed-Forward Loop

I propose that the shift from physiological to pathological pruning is triggered when microglia engulf synapses laden with K63-ubiquitinated tau (or IAPP cross-seeded tau strains). Rather than successfully degrading this highly stable oligomeric strain, the internalized tau interacts with and sequesters microglial p53. While p53 is known to form aggregates in AD brain and interact with tau in neurons, I hypothesize this interaction also occurs within microglia post-phagocytosis, impairing their DNA damage response and driving them into a senescence-associated secretory phenotype (SASP).

Once senescent, these microglia radically alter their exosomal cargo. Instead of merely failing to clear tau, they actively package it. These microglia extrude exosomes co-enriched with K63-tau, C1q, and C3.

Crucially, I propose that these specific microglial-derived exosomes directly target adjacent astrocytes, binding to astrocytic receptors to physically disrupt the anchoring of AQP4 at perivascular endfeet. This exosome-induced AQP4 depolarization functionally collapses the glymphatic clearance system, trapping both amyloid and extracellular tau in the parenchyma and accelerating global neurodegeneration.

Explaining Sex-Specific Vulnerability

This model provides a mechanistic explanation for the observation that males exhibit stronger associations between complement genes and tau pathology. I suggest male microglia possess lower baseline expression of the protective "don't eat me" receptor CD47/SIRPα compared to females. Consequently, male microglia possess a lower threshold for CR3-mediated engulfment of initial K63-tau seeds. They enter the p53-driven senescent, exosome-secreting phase earlier in the disease course, leading to premature astrocytic AQP4 depolarization and a tighter temporal correlation between complement activation and tau burden.

Testability and Falsification

This hypothesis is strictly falsifiable through the following experiments:

1. Exosomal Cargo Profiling: Isolate microglia-derived exosomes from early-stage male vs. female tauopathy mice (e.g., PS19). Male-derived exosomes should show earlier and significantly higher co-enrichment of K63-tau and C3.
2. AQP4 Depolarization Assay: Apply these K63-tau/C3-enriched microglial exosomes to healthy wild-type astrocyte cultures and acute brain slices. If the hypothesis holds, the exosomes will directly induce the mislocalization of AQP4 away from astrocytic endfeet.
3. Microglial p53 Rescue: Generate a microglia-specific conditional knockout of Trp53 in a tauopathy model. This should prevent the senescence shift following K63-tau ingestion, halt the secretion of C3-enriched exosomes, preserve astrocytic AQP4 polarization, and ultimately rescue glymphatic clearance.

By framing glymphatic collapse not as a passive consequence of aging, but as an active phenomenon driven by microglial regurgitation of highly toxic, K63-ubiquitinated tau, we open up highly specific therapeutic windows targeting the microglial-astrocytic exosome axis.